N. Mogulkoc et al., Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection, AM J R CRIT, 160(1), 1999, pp. 349-353
In order to investigate the role of bacteria, including Mycoplasma pneumoni
ae and especially Chlamydia pneumoniae in acute purulent exacerbations of c
hronic obstructive pulmonary disease (COPD), we examined sputum specimens a
nd acute and convalescent sera taken 26 d apart from 49 outpatients experie
ncing an acute purulent exacerbation of COPD. The sera were tested for anti
bodies to C, pneumoniae with the microimmunofluorescence test, and for anti
bodies to M. pneumoniae with the indirect fluorescence antibody test. Routi
ne microbiologic culture of sputum yielded potentially pathogenic microorga
nisms in 12 of the 49 patients (24%). Three patients (6%) showed serologic
evidence of recent M. pneumoniae infection. Seven patients showed high IgG
titers of greater than or equal to 1:1,024 to C. pneumoniae, and an additio
nal four had a fourfold increase in IgG titer, suggesting reinfection with
C. pneumoniae. Sputum from two of these 11 patients also grew Streptococcus
pneumoniae, and one grew Moraxello cotarrhalis. Patients with and without
serologic evidence of current C. pneumoniae infection showed no significant
differences in clinical features or pulmonary function. The high incidence
of infection with C, pneumoniae (the sole causal agent in 16% of cases, an
d the causal agent with other agents in 6%) provides insight into the impor
tance of this organism among agents leading to exacerbations of COPD in Tur
key.